Skip to main content
Caplight Logo









Kanara

Kanara

Private
SpainHealthcare & Life Scienceshttps://kanaralabs.com

Last Round

Seed

Oct 15, 2023

Total Funding Raised

$2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Kanara is a medical supplies company that provides pharmaceutical ingredients intended to improve the quality of life of patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

active plant ingredientsplant cell cultivationcellular agriculturelab-grown ingredientsbioreactor technologyB2B ingredientsbiotechnologysustainable manufacturingbotanical extractspharmaceutical ingredientscosmetic ingredientsnutraceutical ingredientsnon-GMO ingredientspharma supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kanara Comparables

Compare Kanara with similar companies based on industry and business-model similarity.

Kanara comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
In vitro Plant-tech AB
88%
Ayana Bio
84%
ACTV Biotechnology
80%

Kanara Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 15, 2023

Key People

Founding team and executive leadership

Leopoldo Machado Expósito

CEO Y Cofundador

Executive Team

Raúl Clemente García

Chief Operating Officer (COO)

Executive Team

Kanara Investors

Notable investors and investment history

Kanara investors
InvestorRounds
Nexus OneSeed
MarbleXSeed
Gate.ioSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors grew 69% MoM, from 572 to 969.

  • Jun 18, 2026

    Monthly visitors increased 557% MoM, from 87 to 572.

Kanara Filings

Explore SEC and related filing metadata, where available.

Kanara filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kanara's valuation, stock price, and market status.

Is Kanara a public or private company?

Kanara is a private company.

What is the current stock price of Kanara?

Kanara is a private company with no public stock price. No recent secondary market data is available.

How much is Kanara worth (valuation)?

Valuation information for Kanara is not publicly available.

Can I buy Kanara stock?

Kanara shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kanara's last funding round?

Kanara's most recent funding round was Seed on October 15, 2023.

Who are the main investors in Kanara?

Key investors in Kanara include Nexus One, MarbleX, Gate.io.

Will Kanara IPO soon?

No public IPO plans have been announced for Kanara.

How can I track Kanara secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kanara's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSpain
Employee Range8
Year Founded2021
Last FundingOct 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?